EmeraMed Ltd is a cutting-edge biotechnology firm that is revolutionizing the healthcare industry. Their flagship product, Emeramide, is a groundbreaking lipophilic, blood-brain-barrier passing metal chelator and antioxidant. This innovative solution captures free radicals, unstable molecules that can cause extensive damage to your body's cells.

Emeramide also chelates heavy metals like mercury and iron, which would otherwise contribute to the formation of free radicals. By restoring normal function to the mitochondria, Emeramide improves overall health and combats oxidative stress, a root cause of various diseases. The efficacy and safety of Emeramide have been demonstrated in numerous clinical trials, including a Phase 2a trial for COPD and ongoing preclinical studies for other indications.

One particularly exciting application of Emeramide is in the treatment of Covid-19. Given its ability to address the oxidative stress and high iron levels associated with the virus, EmeraMed believes that Emeramide could be a game-changer in the fight against the pandemic. Please note that counterfeit versions of Emeramide are being illegally sold in the EU and USA under different trade names.

We are actively working with regulatory authorities to take action against these dangerous products. Discover the future of health with EmeraMed and unlock the potential for wellness and vitality